Judge Grants Stay In Louisiana Case Challenging Remote Dispensing Of Mifepristone

( April 9, 2026, 2:36 PM EDT) -- LAFAYETTE, La. — Louisiana and a woman, who are challenging the validity of the U.S. Food and Drug Administration’s 2023 decision to remove the in-person dispensing requirement for mifepristone, on April 8 appealed to the Fifth Circuit U.S. Court of Appeals a decision by a federal judge that denied their motion for a preliminary injunction and granted the FDA’s motion to stay the case while the agency conducts a review of its previous rulings....

Attached Documents

Related Sections